Developmental and oncogenic signalling
2021 SGR 01609
![Foto de Developmental and oncogenic signalling](/img/grupo.png)
![Foto de Massachusetts General Hospital](/img/noimage_org.png)
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (3)
2015
-
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer
International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873
2012
-
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia
Histopathology, Vol. 60, Núm. 3, pp. 460-471
2011
-
Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
Laboratory Investigation, Vol. 91, Núm. 6, pp. 859-871